Drug profile · INN
treprostinil diolamine
OREPAXAM
treprostinil diolamine (OREPAXAM) is a prostanoid ip receptor agonist. Associated with United Therapeutics Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Drug details — treprostinil diolamine
- US status
- approved
- Class
- Blood and blood forming organs (B01)
- Route
- ORAL
- Patents
- 9
- Programs
- 1
- Data quality
- 0.89
Quick answer
treprostinil diolamine (OREPAXAM) is a prostanoid ip receptor agonist. Associated with United Therapeutics Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Prostanoid IP receptor agonist
Primary target: Prostacyclin receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| EMA | application withdrawn | — |
Pipeline programs
Related & competitor drugs
Related patents
-
US 11723887
Process to prepare treprostinil, the active ingredient in Remodulin®
granted -
US 9604901
Process to prepare treprostinil, the active ingredient in Remodulin®
granted -
US 9593066
Process to prepare treprostinil, the active ingredient in remodulin®
granted -
US 9393203
Osmotic drug delivery system
granted -
US 8747897
Osmotic drug delivery system
granted -
US 8497393
Process to prepare treprostinil, the active ingredient in Remodulin®
granted -
US 8410169
Compounds and methods for delivery of prostacyclin analogs
granted -
US 8349892
Solid formulations of prostacyclin analogs
granted -
US 7417070
Compounds and methods for delivery of prostacyclin analogs
granted
Frequently asked questions
What is treprostinil diolamine?
treprostinil diolamine (OREPAXAM) is a prostanoid ip receptor agonist. Associated with United Therapeutics Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for treprostinil diolamine?
OREPAXAM is a marketed brand name for treprostinil diolamine. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of treprostinil diolamine?
treprostinil diolamine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.